Regulatory Updates
🇪🇺 EMA Page 4EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 37–48 of 171 articles
Circulating Biomarkers: Additional Evidence Supporting Their Clinical Use in Breast Cancer
Biosimilar Approvals: U.S. vs. Europe Insights for Pharma BD
Key Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights
Tracy Beth Høeg's Departure: Implications for Pharma BD and Regulatory Teams
X4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome
Privosegtor Secures EMA PRIME Designation for Optic Neuritis Treatment
Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma
AbbVie Plans Layoffs: Implications for the Pharma Industry
EMA Approves Novo's Wegovy: A Game Changer in Weight Loss
DEFINITIVE Trial Milestone: 50% Recruitment Achieved
Cynata Therapeutics (ASX:CYP) Surges on European Regulatory Milestone for CYP-001
CinnaGen's Zandoriah Achieves EU Approval for Osteoporosis Treatment